Contact
searchSearch
HMP Global
Login

January/February 2020

Column

Real-World Use of Value-Based Tools and Tracking Outcomes
Editor's Page
Real-World Use of Value-Based Tools and Tracking Outcomes
02/18/2020
Winston Wong, PharmD
High-quality tools have the ability to utilize sophisticated digital mechanisms to improve patient outcomes while also enhancing data collection, lowering costs, and increasing accountability. Clinical pathways and...
High-quality tools have the ability to utilize sophisticated digital mechanisms to improve patient outcomes while also enhancing data collection, lowering costs, and increasing accountability. Clinical pathways and...
...
02/18/2020
Journal of Clinical Pathways
2019 ACCC Survey Respondents Recognize Care Standardization as Opportunity for Cost Savings
Trending From ACCC
2019 ACCC Survey Respondents Recognize Care Standardization as Opportunity for Cost Savings
02/18/2020
In January, the Association of Community Cancer Centers (ACCC) released results of the “2019 Trending Now in Cancer Care Survey.” This marks the 10th year of the annual ACCC survey, which is designed to...
In January, the Association of Community Cancer Centers (ACCC) released results of the “2019 Trending Now in Cancer Care Survey.” This marks the 10th year of the annual ACCC survey, which is designed to...
...
02/18/2020
Journal of Clinical Pathways
Where Will Health Care Take Us in the 2020s?
Pharma Insights
Where Will Health Care Take Us in the 2020s?
02/18/2020
David B. Carr, PhD, MD, CMD; Larry Blandford, PharmD
As we say goodbye to the 2010s, we look at the prevailing trends and project forward to what we think are the key topics to consider in the coming decade—not an easy task. Looking back at commentary and predictions...
As we say goodbye to the 2010s, we look at the prevailing trends and project forward to what we think are the key topics to consider in the coming decade—not an easy task. Looking back at commentary and predictions...
As we...
02/18/2020
Journal of Clinical Pathways
Clinical Pathways and Policy to Guard Against Misaligned Incentives
Clinical Pathways GPS
Clinical Pathways and Policy to Guard Against Misaligned Incentives
02/18/2020
Seth Gordon, MBA; Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
The application of clinical pathways and their enforcement through quality metric benchmark setting and appropriate use criteria is needed to guard against perverse financial incentives that encourage...
The application of clinical pathways and their enforcement through quality metric benchmark setting and appropriate use criteria is needed to guard against perverse financial incentives that encourage...
The...
02/18/2020
Journal of Clinical Pathways
A Framework for Person-Centered Care Pathways in Oncology
PATIENT PERSPECTIVE
A Framework for Person-Centered Care Pathways in Oncology
02/18/2020
Alan J. Balch, PhD, MSc
Historically, the development of clinical pathways has been effective in treatment planning for cancer care. In line with the increasing sophistication of pathways, it is time to consider how patient-specific...
Historically, the development of clinical pathways has been effective in treatment planning for cancer care. In line with the increasing sophistication of pathways, it is time to consider how patient-specific...
...
02/18/2020
Journal of Clinical Pathways
Recognizing the Limitations Surrounding Clinical Pathways to Ensure Appropriate Use
Tools for Transformation
Recognizing the Limitations Surrounding Clinical Pathways to Ensure Appropriate Use
02/18/2020
Gordon Kuntz
Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...
Gordon Kuntz is a health care consultant and strategic advisor with over 30 years’ experience in a multitude of health care settings, working with payers and providers, and in technology and strategy. He began his...
...
02/18/2020
Journal of Clinical Pathways

Feature

Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States
Research Reports
Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States
02/18/2020
Andrew J. Klink, PhD, MPH; Anna G. Purdum, PharmD, MS; Chadi Nabhan, MD, MBA, FACP; Bruce A. Feinberg, DO; Choo Hyung Lee, MS; Yin Yang, MS; JaLyna Laney, RN, OCN
Abstract: Given new therapeutic advances that are potentially curative in diffuse large B-cell lymphoma (DLBCL), it is important to understand what has been observed to date in this population to assess improvement...
Abstract: Given new therapeutic advances that are potentially curative in diffuse large B-cell lymphoma (DLBCL), it is important to understand what has been observed to date in this population to assess improvement...
...
02/18/2020
Journal of Clinical Pathways
Use of Clinical Decision Support and Peer Review to Increase NCCN Guideline Adherence
Research Reports
Use of Clinical Decision Support and Peer Review to Increase NCCN Guideline Adherence
02/18/2020
Margaret Rausa, PharmD; Stephen Hamilton, MD; David Spangler; Eric Gratias, MD, FAAP
Abstract: eviCore healthcare uses the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®) to support its proprietary program for medical oncology drug management. The...
Abstract: eviCore healthcare uses the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®) to support its proprietary program for medical oncology drug management. The...
...
02/18/2020
Journal of Clinical Pathways
JCP January/February 2025

Current Issue

February 2025
Volume 11
Issue 1
Current Issue
Issue Archive

Special Reports

Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
Edward Arrowsmith, MD; Vishnukamal Golla, MD, MPH; Rhonda Henschel, MBA; Andrew Hertler, MD, FACP; David Jackman, MD; Gordon Kuntz; Olaf Lodbrok, MS, MBA; Carole Tremonti, RN, MBA; Lalan Wilfong, MD
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Robin T. Zon, MD, FACP, FASCO; Gordon Kuntz; Winston Wong, PharmD
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Volume 6

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use